Drug Raises Serum Albumin
Megestrol acetate (MA) may safely increase serum albumin in malnourished dialysis patients, according to researchers in Iran.
Diagnosis & Disease Information
Health-Care Sector Relatively Stable
Health stocks have long served as defensive holdings—investments that will not collapse in downturns. After all, consumers still buy drugs and visit physicians during recessions. This year some pharmaceutical stocks provided protection, avoiding big losses while almost every other industry sank deeply into the red.
Drugs Benefit Patients with Heart and Renal Failure
NEW ORLEANS—Most heart failure patients with renal failure can be managed successfully with ACE inhibitors or angiotensin receptor blockers (ARBs), and the treatment is associated with better outcomes, said Virgina B. Thayer, MS, at the 2008 scientific sessions of the American Heart Association.
Alfuzosin Treatment for BPH Improves Sexual Function
Patients who receive alfuzosin as treatment for benign prostatic hyperplasia (BPH) experience improvements in sexual function as well lower urinary tract symptoms (LUTS), a South Korean study suggests.
Myocardial Perfusion Found to Decline with Hemodialysis
Hemodialysis (HD) is associated with a pronounced drop in myocardial perfusion, a study shows.
Current Smokers Diagnosed with Bladder Cancer Earlier
Bladder cancer is diagnosed about six years earlier in current smokers than in current nonsmokers, according to Japanese investigators.
Unilateral PCa Difficult to Predict
Biopsy findings of unilateral prostate cancer are unreliable for identifying candidates for hemi-ablative focal therapy, according to researchers.
Chewing Gum Aids Phosphate Control
Adding salivary phosphate-binding chewing gum to traditional phosphate-binder therapy could improve hyperphosphatemia control in hemodialysis (HD) patients, data show.
Hyperoxaluria After Bariatric Surgery
Patients with no history of kidney stones have a high prevalence of hyperoxaluria following bariatric surgery, researchers reported in The Journal of Urology (2009;181:161-166).
Intrarenal Infusions Aid AKI Recovery
HOLLYWOOD, Fla.— Using a novel drug-delivery system to infuse fenoldopam and other vasodilators directly into the kidneys may improve recovery from acute kidney injury (AKI), according to a small study showing that this approach dramatically reduced 28-day mortality when compared with historical outcomes.
- Loading...
Loading...
Loading... 
Loading...